<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Diabetes Res</journal-id><journal-id journal-id-type="iso-abbrev">J Diabetes Res</journal-id><journal-id journal-id-type="pmc-domain-id">2082</journal-id><journal-id journal-id-type="pmc-domain">jdrsch</journal-id><journal-id journal-id-type="publisher-id">JDR</journal-id><journal-title-group><journal-title>Journal of Diabetes Research</journal-title></journal-title-group><issn pub-type="ppub">2314-6745</issn><issn pub-type="epub">2314-6753</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11922610</article-id><article-id pub-id-type="pmcid-ver">PMC11922610.1</article-id><article-id pub-id-type="pmcaid">11922610</article-id><article-id pub-id-type="pmcaiid">11922610</article-id><article-id pub-id-type="pmid">40109952</article-id><article-id pub-id-type="doi">10.1155/jdr/8830658</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Diabetes Screening in the Emergency Department: Development of a Predictive Model for Elevated Hemoglobin A1c</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7303-6579</contrib-id><name name-style="western"><surname>Smart</surname><given-names initials="MH">Mary H.</given-names></name><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4347-5060</contrib-id><name name-style="western"><surname>Lin</surname><given-names initials="JY">Janet Y.</given-names></name><xref rid="I2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2176-5654</contrib-id><name name-style="western"><surname>Layden</surname><given-names initials="BT">Brian T.</given-names></name><xref rid="I3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="I4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4274-7431</contrib-id><name name-style="western"><surname>Eisenberg</surname><given-names initials="Y">Yuval</given-names></name><xref rid="I3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5645-7091</contrib-id><name name-style="western"><surname>Pickard</surname><given-names initials="AS">A. Simon</given-names></name><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7809-9042</contrib-id><name name-style="western"><surname>Sharp</surname><given-names initials="LK">Lisa K.</given-names></name><xref rid="I5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9077-2092</contrib-id><name name-style="western"><surname>Danielson</surname><given-names initials="KK">Kirstie K.</given-names></name><xref rid="I3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-6914-5724</contrib-id><name name-style="western"><surname>Kong</surname><given-names initials="A">Angela</given-names></name><email>akong@uic.edu</email><xref rid="I1" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="I1">
<sup>1</sup>Department of Pharmacy Systems, Outcomes and Policy, College of Pharmacy, The University of Illinois Chicago, Chicago, Illinois, USA</aff><aff id="I2">
<sup>2</sup>Department of Emergency Medicine, College of Medicine, The University of Illinois Chicago, Chicago, Illinois, USA</aff><aff id="I3">
<sup>3</sup>Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The University of Illinois Chicago, Chicago, Illinois, USA</aff><aff id="I4">
<sup>4</sup>Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, USA</aff><aff id="I5">
<sup>5</sup>Department of Biobehavioral Nursing Science, College of Nursing, The University of Illinois Chicago, Chicago, Illinois, USA</aff><author-notes><fn fn-type="other"><p>Academic Editor: Daniela Foti</p></fn></author-notes><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>12</day><month>3</month><year>2025</year></pub-date><volume>2025</volume><issue-id pub-id-type="pmc-issue-id">479124</issue-id><elocation-id>8830658</elocation-id><history><date date-type="received"><day>18</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>4</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>19</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-20 16:25:16.570"><day>20</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Mary H. Smart et al. Journal of Diabetes Research published by John Wiley &amp; Sons Ltd.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JDR2025-8830658.pdf"/><abstract><p>
<bold>Aims:</bold> We developed a prediction model for elevated hemoglobin A1c (HbA1c) among patients presenting to the emergency department (ED) at risk for diabetes to identify important factors that may influence follow-up patient care.</p><p>
<bold>Methods:</bold> Retrospective electronic health records data among patients screened for diabetes at the ED in May 2021 was used. The primary outcome was elevated HbA1c (&#8805;&#8201;5.7%). The data was divided into a derivation set (80%) and a test set (20%) stratified by elevated HbA1c. In the derivation set, we estimated the optimal significance level for backward elimination using a 10-fold cross-validation method. A final model was derived using the entire derivation set and validated on the test set. Performance statistics included C-statistic, sensitivity, specificity, predictive values, Hosmer&#8211;Lemeshow test, and Brier score.</p><p>
<bold>Results:</bold> There were 590 ED patients screened for diabetes in May 2021. The final model included nine variables: age, race/ethnicity, insurance, chief complaints of back pain and fever/chills, and a past medical history of obesity, hyperlipidemia, chronic obstructive pulmonary disease, and substance misuse. Adequate model discrimination (C&#8722;statistic = 0.75; sensitivity, specificity, and predictive&#8201;values &gt; 0.70), no evidence of model ill fit (Hosmer&#8211;Lemeshow test = 0.29), and moderate Brier score (0.21) suggest acceptable model performance.</p><p>
<bold>Conclusion:</bold> In addition to age, obesity, and hyperlipidemia, a history of substance misuse was identified as an important predictor of elevated HbA1c levels among patients screened for diabetes in the ED. Our findings suggest that substance misuse may be an important factor to consider when facilitating follow-up care for patients identified with prediabetes or diabetes in the ED and warrants further investigation. Future research efforts should also include external validation in larger samples of ED patients.</p></abstract><funding-group><award-group><funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://dx.doi.org/10.13039/501100004191">Novo Nordisk</funding-source><award-id>ISS-001235</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>There are over 37 million US adults with diabetes, and of those, 20% are unaware that they have diabetes [<xref rid="B1" ref-type="bibr">1</xref>]. The United States Preventive Task Force recommends routine screening of adults at risk for diabetes, which has typically been conducted in the primary care setting [<xref rid="B2" ref-type="bibr">2</xref>]. However, certain populations, such as racially and ethnically minoritized populations, may face barriers to primary care utilization and, as a result, are less likely to be screened for diabetes [<xref rid="B3" ref-type="bibr">3</xref>]. Diabetes screening in the acute care setting may act as a safety net for these populations, who tend to use emergency care services more frequently [<xref rid="B3" ref-type="bibr">3</xref>&#8211;<xref rid="B5" ref-type="bibr">5</xref>]. However, connecting patients screened positive for either diabetes or prediabetes among previous efforts to implement diabetes screening within the emergency department (ED) to follow-up care has been poor [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>]. Understanding the characteristics of patients identified with newly diagnosed diabetes or prediabetes in the ED may be important to inform strategies linking these patients to services within primary care.</p><p>The ED stands apart from other healthcare settings because it provides accessible and timely care for an array of serious and acute medical situations, regardless of an individual's ability to pay [<xref rid="B8" ref-type="bibr">8</xref>]. This contrasts with primary care, which often requires scheduling appointments ahead of time, is unavailable 24/7, and may only accept certain types of insurance [<xref rid="B4" ref-type="bibr">4</xref>]. Consequently, the ED setting often acts as a safety net for diverse patient populations [<xref rid="B5" ref-type="bibr">5</xref>]. For example, the ED population tends to have a higher proportion of individuals with serious illness or injury who are seeking immediate care compared to the general population [<xref rid="B4" ref-type="bibr">4</xref>]. Additionally, racially and ethnically minoritized populations are more likely to use emergency services as a safety-net facility than other health services due to barriers to primary care access, needing timely access to care, and mistrust of the medical community [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B9" ref-type="bibr">9</xref>]. Furthermore, since the ED serves patients regardless of their insurance status, it is more likely to see uninsured and underinsured populations than other healthcare settings [<xref rid="B10" ref-type="bibr">10</xref>]. Ultimately, the unique function of the ED leads to differences between those who frequent the ED and the general patient population. As a result, the ED setting, with its distinct patient population, makes it challenging for one-size-fits-all prediction models to accurately capture the intricacies of the acute care setting [<xref rid="B11" ref-type="bibr">11</xref>]. Therefore, if a prediction model is developed primarily on the general patient population, its applicability to specific populations, like those seen in the ED, may be limited [<xref rid="B12" ref-type="bibr">12</xref>].</p><p>Clinical prediction models are useful tools to help identify patients at an increased risk for a medical condition and aid healthcare professionals in making informed decisions about patient care [<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B14" ref-type="bibr">14</xref>]. Several diabetes prediction models and risk assessment tools have been developed to estimate individuals at risk of developing diabetes [<xref rid="B15" ref-type="bibr">15</xref>&#8211;<xref rid="B17" ref-type="bibr">17</xref>]. However, most of these models have been developed and validated in populations not representative of those seen in the acute care setting [<xref rid="B18" ref-type="bibr">18</xref>&#8211;<xref rid="B20" ref-type="bibr">20</xref>]. As a result, there may be factors specific to patients presenting to the ED that are not represented in current risk prediction tools [<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B19" ref-type="bibr">19</xref>]. These factors may be important to consider in developing and implementing effective strategies for linking ED patients to prevention and treatment services beyond the ED setting. Therefore, we aimed to develop a prediction model of elevated hemoglobin A1c (HbA1c) among those screened for diabetes within the ED using demographic and clinical characteristics measured during the ED visit. Our goal was to identify predictors of elevated HbA1c within the acute care setting to better understand the patient population served by the ED-based diabetes screening program.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Background</title><p>In 2020, the University of Illinois Hospital and Health Sciences System, a large urban academic medical center in Chicago serving a predominantly racially and ethnically minoritized population and Medicaid recipients, implemented a routine, electronic medical record (EMR)-based diabetes screening program within the ED. The goal of the program was to identify patients with undiagnosed prediabetes or diabetes and facilitate linkage to primary care. An HbA1c test using high-performance liquid chromatography was added to an existing lab order for eligible patients identified using a best practice alert embedded in the EMR informed by the American Diabetes Association's guidelines. HbA1c values &#8805;&#8201;5.7% were considered elevated. Patients with a previous diagnosis of diabetes were ineligible for HbA1c testing and excluded from the cohort. A further description of the program is provided elsewhere [<xref rid="B21" ref-type="bibr">21</xref>].</p></sec><sec id="sec2.2"><title>2.2. Study Design and Source of Data</title><p>We conducted a cross-sectional study using data extracted from the EMR. Data was collected using automatically generated EMR reports and manual data extraction. Manual chart extraction used a double-entry method, and personnel entering data met regularly to resolve discrepancies. The study followed the TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) guidance for prediction model development and validation [<xref rid="B22" ref-type="bibr">22</xref>]. The University of Illinois Chicago's Institutional Review Board reviewed and approved this study (Protocol: 2021-1048).</p></sec><sec id="sec2.3"><title>2.3. Sample Population</title><p>The study included all adult patients (&#8805;&#8201;18 years) screened for diabetes in the ED in May 2021. Patients were screened based on American Diabetes Association screening guidelines using an EMR-based algorithm [<xref rid="B23" ref-type="bibr">23</xref>]. Eligible patients for screening were as follows: (1) those &#8805;&#8201;45 years of age or (2) &#8805;18 years with BMI &#8805; 25&#8201;kg/m<sup>2</sup>. Any patients with a previous diagnosis of diabetes or who had an HbA1c test recorded in their hospital medical record within 3 years of their ED visit were ineligible for screening.</p></sec><sec id="sec2.4"><title>2.4. Outcome Measure</title><p>The prediction outcome of interest was an elevated (i.e., &#8805;&#8201;5.7%) HbA1c value, indicative of possible undiagnosed prediabetes or diabetes among those who were screened for diabetes in the ED. The outcome was dichotomized (i.e., elevated vs. normal (&lt;&#8201;5.7%) HbA1c value).</p></sec><sec id="sec2.5"><title>2.5. Candidate Variables</title><p>Among the baseline variables collected, candidate variables were selected based on clinical expertise and previous literature on factors associated with prediabetes and diabetes [<xref rid="B24" ref-type="bibr">24</xref>]. We assessed for multicollinearity between variables using a correlation matrix and variance inflation factor (&gt;&#8201;5) [<xref rid="B25" ref-type="bibr">25</xref>]. Investigators (M.H.S. and A.K.) met to decide which variables to retain among those that exhibited correlations. Bivariate analysis was conducted for each candidate predictor and the outcome of interest using a chi-square test and <italic toggle="yes">t</italic>-test for categorical and continuous variables, respectively. Variables that exhibited a significant association with the outcome at a <italic toggle="yes">p</italic> value of &lt;&#8201;0.20 were retained for model evaluation. Of the candidate variables evaluated, 17 candidate predictor variables were retained for multivariable regression model development and validation.</p><p>The final candidate variables included patient age (years), sex (male, female), and race/ethnicity (non-Hispanic White; non-Hispanic Black or African American; non-Hispanic Asian; Hispanic, Latino(a), or Spanish origin; or other/unknown). Insurance types included commercial/private, Medicaid, Medicare, and other/unknown/uninsured. Past medical history was defined as any current or past major illnesses or comorbidities listed in the patient's medical record or mentioned in the doctors' notes during the ED visit. The patient's past social history was not evaluated. Patients presenting with a BMI &#8805; 30&#8201;kg/m<sup>2</sup> were identified as obese. Substance misuse was defined as any (poly)substance disorder, misuse, or abuse of any of the following: alcohol, opioids, nicotine/tobacco, and cannabis noted within the patient's past medical history or during the current ED visit. Cardiovascular disease included medical history of myocardial infarction, venous thromboembolism, and atherothrombosis. A chief complaint is defined as the main reason for ED visits. The candidate predictors were assessed for missingness. Candidate predictors displayed no more than 5% missingness and none for the outcome.</p></sec><sec id="sec2.6"><title>2.6. Statistical Analysis</title><p>Data cleaning and analysis were conducted using SAS 9.4 software (SAS Institute, Cary, North Carolina, United States). The cohort was split into a derivation set (80%) and a test set (20%), stratified by HbA1c status (i.e., elevated vs. normal) to ensure similar outcome proportions across the two datasets. Descriptive statistics were performed on the candidate predictors using frequencies and proportions for categorical and mean with standard deviations for continuous variables on the total, derivation, and test sets.</p><p>Multivariable logistic regression using backward elimination was based on the Akaike information criteria to account for a small sample size [<xref rid="B26" ref-type="bibr">26</xref>]. The optimal significance value for variable retention was determined by conducting a 10-fold cross-validation of logistic regression models using backward elimination based on significance levels of 0.01, 0.05, 0.157, and 0.25 [<xref rid="B27" ref-type="bibr">27</xref>]. These were compared to a model including all candidate variables. Our aim in using a 10-fold cross-validation technique was to identify the most ideal significance level, avoiding a <italic toggle="yes">p</italic> value too small that would exclude important predictors or too high a value that resulted in including unnecessary erroneous predictors [<xref rid="B26" ref-type="bibr">26</xref>]. Additionally, the frequency by which the parameters were selected across the different model strategies was compiled. Performance measures for each model were compared to determine the optimal <italic toggle="yes">p</italic>-value for the final model.</p><p>A final model was derived using the entire derivation set and then internally validated on the test set. The C-statistic, sensitivity, and specificity were used to determine model discrimination, which is how well the model can discriminate between those with elevated versus normal HbA1c levels [<xref rid="B28" ref-type="bibr">28</xref>]. The Hosmer&#8211;Lemeshow test was used to assess model fit and calibration, which is the level of agreement between observed probability and predicted probability of the outcome [<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B29" ref-type="bibr">29</xref>]. Scaled Brier score, a measure assessing both discrimination and calibration, was used to represent overall prediction performance (with performance values depending on outcome prevalence) [<xref rid="B29" ref-type="bibr">29</xref>].</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Participant Characteristics</title><p>There were 3290 ED admissions in May 2021, with 590 (18%) adults screened for diabetes that were included in this study. Demographic and clinical characteristics of the cohort using candidate variables are reported in <xref rid="tab1" ref-type="table">Table 1</xref>. In general, those with elevated HbA1c levels (i.e., &#8805;&#8201;5.7%) were older (57 vs. 48, <italic toggle="yes">p</italic> &lt; 0.001). There were also differences in racial/ethnic backgrounds across the two groups, with more non-Hispanic Blacks or African Americans and non-Hispanic Asians within the elevated HbA1c group (<italic toggle="yes">p</italic> = 0.04). Compared to those with normal HbA1c levels, those with elevated HbA1c were more likely to have comorbidities or a past medical history of hypertension, obesity, hyperlipidemia, cardiovascular disorder, arthritis, chronic obstructive pulmonary disease (COPD), cancer, and substance misuse. Finally, those with elevated HbA1c levels were more likely to present to the ED with a chief complaint of back pain and a chief complaint of fever and/or chills than those with normal HbA1c levels.</p><p>The derivation set contained 457 observations with 208 (45.5%) abnormal HbA1c levels, and the test set contained 113 observations with 51 (45.1%) elevated HbA1c levels. A comparison of the derivation and test set across the candidate variables can be seen in Appendix Table <xref rid="supplementary-material-1" ref-type="sec">S1</xref>. There was no statistically significant difference between the derivation and test cohort except for the race/ethnicity category (<italic toggle="yes">p</italic> &lt; 0.01), which was driven mainly by the non-Hispanic Asian category.</p></sec><sec id="sec3.2"><title>3.2. Model Derivation</title><p>There were 50 models generated using the 10-fold cross-validation. All models displayed no evidence of poor fit. While there was no statistical difference between the modeling strategies (i.e., models of differing <italic toggle="yes">p</italic> values and all predictors) in C-statistic (<italic toggle="yes">p</italic> = 0.65) or Brier score (<italic toggle="yes">p</italic> = 0.71), the modeling strategy with the highest average C-statistic (0.74) and lowest average Brier score (0.21) was <italic toggle="yes">p</italic>&#8201;value = 0.157. Box plots of the average C-statistics and Brier score, along with means and standard deviations, can be seen in Appendix Figures <xref rid="supplementary-material-1" ref-type="sec">S1</xref> and <xref rid="supplementary-material-1" ref-type="sec">S2</xref>. The variables that were selected at least 75% across all 50 models were as follows: a history of obesity, substance misuse, and hyperlipidemia;age; insurance status; and a chief complaint of back pain (Appendix Table <xref rid="supplementary-material-1" ref-type="sec">S2</xref>).</p><p>Our final model was developed on the entire derivation dataset using a multivariable logistic regression model with backward elimination at a significance level of 0.157. <xref rid="tab2" ref-type="table"> Table 2</xref> shows the point estimates for the final model with standard errors and 95% confidence intervals. The final model included nine variables, which were age, race/ethnicity, insurance, and a past medical history of obesity, hyperlipidemia, COPD, and substance misuse, along with chief complaints of back pain and fever/chills.</p></sec><sec id="sec3.3"><title>3.3. Internal Validation</title><p>The performance of the final model on the test cohort can be seen in <xref rid="tab3" ref-type="table">Table 3</xref>. The prediction model demonstrated adequate ability to discriminate between normal versus elevated HbA1c among the ED diabetes screened population, as indicated by a C-statistic of 0.75 and sensitivity and specificity &gt; 0.70&#8201;[<xref rid="B28" ref-type="bibr">28</xref>]. The negative predictive value was 0.73, while the positive predictive value was 0.67, which suggests that the model has better discriminative ability in detecting the absence of the outcome given a normal HbA1c result [<xref rid="B30" ref-type="bibr">30</xref>].</p><p>A visual comparison of the area under the receiver operating characteristic curve (AUC) for the final model on the derivation (0.77) versus the test cohort (0.75) can be seen in Appendix Figure <xref rid="supplementary-material-1" ref-type="sec">S3</xref>. The Hosmer&#8211;Lemeshow test was not statistically significant (<italic toggle="yes">p</italic> = 0.29), indicating adequate calibration [<xref rid="B28" ref-type="bibr">28</xref>]. The Brier score was 0.21, which is moderate given the outcome proportion was almost half the population and may suggest a need for to update the algorithm during future validation efforts [<xref rid="B28" ref-type="bibr">28</xref>].</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>We developed a prediction model for elevated HbA1c among ED patients determined to be at risk for diabetes. Our goal was to identify important predictors of elevated HbA1c specific to the acute care setting that may not be reflected in current diabetes risk tests typically administered in the primary care setting [<xref rid="B2" ref-type="bibr">2</xref>]. To our knowledge, this is the first prediction model of elevated HbA1c among those screened for diabetes in an acute care setting and can have important implications for diabetes screening initiatives within the ED. Our findings highlighted that in addition to age, obesity, and hyperlipidemia, a history of substance misuse is an important predictor of elevated HbA1c in the acute care setting. These findings may suggest an important role for substance misuse, though further research is needed to elucidate its relationship with elevated HbA1c results (i.e., casual versus noncasual relationship).</p><p>Four variables were selected 90% of the time across the k-fold models: age, and a history of substance misuse, obesity, and hyperlipidemia. The association of age, obesity, and hyperlipidemia with diabetes and prediabetes is well established [<xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B32" ref-type="bibr">32</xref>]. Interestingly, our model identified substance misuse as a significant predictor of elevated HbA1c among at-risk patients in the ED. This suggests that a history of substance misuse may be an important factor to consider when facilitating postscreening care, such as diabetes prevention or management in primary care, for ED patients with a potentially new diagnosis of prediabetes and diabetes.</p><p>The prevalence of individuals with a history of substance misuse presenting to the ED likely explains the presence and importance of substance misuse in our predictive model. In 2021, substance misuse, including alcohol and illicit drug misuse, abuse, and dependency, is estimated to be present in over 11% of ED visits in the United States [<xref rid="B33" ref-type="bibr">33</xref>] Our study aligns with national reports, with a prevalence of 9% substance misuse in our study cohort. Patients with a history of substance misuse are more likely to frequent emergency services rather than engage with primary care [<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B34" ref-type="bibr">34</xref>]. Furthermore, attempts to link patients to primary care from the ED with a history of substance misuse have been met with challenges due to reported barriers such as stigma and patient-experienced healthcare costs [<xref rid="B35" ref-type="bibr">35</xref>&#8211;<xref rid="B37" ref-type="bibr">37</xref>]. Therefore, considering the characteristics and needs of patients with a history of substance misuse may be essential to successfully linking ED patients identified with elevated HbA1c for follow-up treatment and prevention services within routine care and warrants further examination.</p><p>Additionally, literature has reported poor glycemic control among patients with a history of substance use disorder, a clinical diagnosis for patients with chronic misuse of substances [<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>]. Alcohol and recreational drug use are associated with the incidence of Type 2 diabetes [<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>]. Patients with a history of substance misuse may have poor prediabetes and diabetes-related outcomes due to the impact of social determinants of health [<xref rid="B42" ref-type="bibr">42</xref>]. Social determinants, such as food and housing insecurity, lack of neighborhood safety, and lack of insurance, make diabetes prevention and management challenging for these patients since treatment regimens often include intense lifestyle modification (i.e., healthy eating and physical activity) and/or prescription medication [<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B41" ref-type="bibr">41</xref>, <xref rid="B43" ref-type="bibr">43</xref>]. Patients unable to engage in lifestyle modification, access, and adhere to treatment regimens due to their circumstances and environment that require extraordinary efforts to overcome barriers to being healthy will be less likely to manage their prediabetes or diabetes [<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>]. On the other hand, engagement with treatment of substance misuse is associated with improved HbA1c control [<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>]. Our findings suggest the successful linkage and delivery of diabetes treatment and prevention services in primary care may need to address substance misuse and interventions sensitive to social determinants of health.</p><p>Our prediction model differs from other prominent diabetes and prediabetes prediction models in several ways. First, most reported diabetes prediction models, such as the American Diabetes Association's diabetes and prediabetes risk calculators, have been developed and validated in the general population, which is typically utilized to inform routine care [<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B18" ref-type="bibr">18</xref>&#8211;<xref rid="B20" ref-type="bibr">20</xref>]. To identify characteristics specific to patients seen in acute care that may influence postscreening referral to primary care, the source population for our model was a subset of patients already determined to be at risk for diabetes who presented to the ED. Additionally, we did not include a family history of diabetes or prediabetes as a candidate predictor since it is often poorly documented within patient medical charts, particularly among certain ethnically minoritized populations [<xref rid="B45" ref-type="bibr">45</xref>]. Finally, previous diabetes risk assessment tools have identified hypertension to be a strong risk factor for diabetes and prediabetes [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B18" ref-type="bibr">18</xref>]. However, the covariate for a history of hypertension was not included in our final model. A studentized <italic toggle="yes">t</italic>-test showed that age was strongly associated (<italic toggle="yes">p</italic> &lt; 0.01) with hypertension and other comorbidities like obesity, hyperlipidemia, and cardiovascular disorder despite not meeting the threshold for elimination for multicollinearity during model development.</p><p>Our study has some notable limitations. First, our sample size is relatively small, which may lead to unstable parameter estimates and overfitting [<xref rid="B46" ref-type="bibr">46</xref>]. However, we utilized the Akaike information criterion to account for the small sample size [<xref rid="B26" ref-type="bibr">26</xref>]. Future studies in larger external ED populations will be necessary to validate the model further and to possibly update the algorithm. We did not utilize data imputation given that our outcome and candidate predictors were nearly complete and had a relatively small sample size, which may have resulted in inefficiencies and potential bias predictors [<xref rid="B26" ref-type="bibr">26</xref>]. Also, variables associated with past medical history, including substance misuse, may have included past but not active medical conditions.</p><p>Additionally, our study cohort is comprised of those who were screened for diabetes within the ED. As expected, the baseline characteristics of those who were screened and not screened were slightly different since the screening algorithm used to identify at-risk patients included parameters set by the American Diabetes Association screening guidelines. For example, those who were screened versus not screened were older (51 vs. 46, <italic toggle="yes">p</italic> &lt; 0.01) and more likely male (50% vs. 36%, <italic toggle="yes">p</italic> &lt; 0.01). Therefore, our conclusions can only be generalized to those deemed at-risk for diabetes within the ED and not to the entire ED population.</p><p>Importantly, since the goal of the study was to develop a predictive model and optimize the predictive power of a group of variables, it would be misleading to interpret the individual beta coefficients [<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>]. Therefore, we are unable to make causal inferences of, for example, a history of substance misuse on having an elevated abnormal HbA1c level. However, our model does point to the possible importance of a history of substance misuse in being at risk for diabetes among patients presenting to the ED that warrants further exploration.</p><p>Furthermore, our study sample was collected during the COVID-19 pandemic, which may affect the generalizability of our findings. For example, a chief complaint of fever and chills was an important predictor in our model, which suggests the influence of the COVID-19 pandemic on our cohort utilized in building the model. Patient hospitalizations and ED admissions varied considerably before, during, and after the pandemic attributed to the COVID-19 lockdowns and restrictions [<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B50" ref-type="bibr">50</xref>]. Therefore, the types of patients presenting to the ED during the COVID-19 lockdown may not reflect those seen beyond the pandemic period. However, we believe the implications of our predictive model are relevant to the ED population irrespective of the COVID-19 pandemic since the prevalence of substance misuse has been pervasive before and through the pandemic [<xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B52" ref-type="bibr">52</xref>]. Future studies should evaluate the model's validity in populations unaffected by a major health event like the COVID-19 pandemic.</p><p>In conclusion, our model provides insight into important ED patient characteristics predictive of elevated HbA1c that are not captured in existing diabetes and prediabetes prediction models. In addition to age, obesity, and hyperlipidemia, a history of substance misuse was identified as an important predictor of elevated HbA1c among patients screened for diabetes in the ED. Considering potential substance misuse among ED patients may be critical for successful linkage to primary care and management of hyperglycemia beyond the acute care setting. Our work informs ongoing development and strategies of existing diabetes screening initiatives within and beyond the acute care setting. Future research efforts include external validation in larger ED populations, including broader time periods, rural settings, and regions beyond the Chicago metropolitan area.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would also like to thank Dr. Todd A. Lee for his mentorship and guidance in the analytical approaches for the study.</p></ack><sec sec-type="data-availability"><title>Data Availability Statement</title><p>The data that supports the findings of this study may be available upon request from the corresponding author. The data is not publicly available due to privacy or ethical restrictions.</p></sec><sec sec-type="ethics-statement"><title>Ethics Statement</title><p>The University of Illinois Chicago's Institutional Review Board reviewed and approved this study (Protocol: 2021-1048).</p></sec><sec><title>Disclosure</title><p>This work is based on research conducted as part of the lead author's doctoral dissertation at the University of Illinois Chicago, which was successfully defended in December 2023.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>J.Y.L. reported receiving grant funding from Novo Nordisk A/S during the conduct of the study and Xeris Biopharma Holdings Inc. outside of the submitted work. B.T.L. is supported by the National Institutes of Health under Award Number R01DK104927 and P30DK020595 and the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, VA merit (Grant No. 1I01BX003382). K.K.D. reported receiving grant funding from Novo Nordisk A/S during the conduct of this study. The other authors declare no conflicts of interest.</p></sec><sec><title>Author Contributions</title><p>Mary Smart: conceptualization, methodology, formal analysis, writing&#8212;original draft. Janet Lin: funding acquisition, project administration. Brian Layden: funding acquisition, project administration. Yuval Eisenberg: project administration. A. Simon Pickard: conceptualization, writing&#8212;review and editing. Lisa Sharp: conceptualization, writing&#8212;review and editing. Kristie Danielson: data curation, resources. Angela Kong: conceptualization, supervision, writing&#8212;review and editing.</p></sec><sec><title>Funding</title><p>This independent investigator-initiated study received funding support from Novo Nordisk A/S (grant number: ISS-001235) (principal investigators: J.Y.L. and B.T.L.).</p></sec><sec sec-type="supplementary-material" id="supplementary-material-1"><title>Supporting Information</title><p>Additional supporting information can be found online in the Supporting Information section.</p><supplementary-material id="supp-1" position="float" content-type="local-data" orientation="portrait"><label>Supporting Information 1</label><caption><p>Appendix Table S1: a comparison of the derivation and test set across the candidate variables.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8830658.f1.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="supp-2" position="float" content-type="local-data" orientation="portrait"><label>Supporting Information 2</label><caption><p>Appendix Table S2: frequency of variables selected across 40 models (excluding models with all variables).</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8830658.f2.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="supp-3" position="float" content-type="local-data" orientation="portrait"><label>Supporting Information 3</label><caption><p>Appendix Figure S1: box plot of the average C-statistic across the 10-folds for each model with varying <italic toggle="yes">p</italic> values.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8830658.f3.png" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="supp-4" position="float" content-type="local-data" orientation="portrait"><label>Supporting Information 4</label><caption><p>Appendix Figure S2: box plot for the average Brier score across 10-folds for each model with varying <italic toggle="yes">p</italic> values.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8830658.f4.png" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="supp-5" position="float" content-type="local-data" orientation="portrait"><label>Supporting Information 5</label><caption><p>Appendix Figure S3: the receiver operating characteristic curve (AUC) for the final model on the derivation and test cohort.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="8830658.f5.png" position="float" orientation="portrait"/></supplementary-material></sec><ref-list><ref id="B1" content-type="misc"><label>1</label><element-citation publication-type="other"><collab>Centers for Disease Control and Prevention</collab><article-title>National Diabetes Statistics Report website</article-title><comment>Updated June 29, 2022. Accessed October 7, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/diabetes/data/statistics-report/index.html" ext-link-type="uri">https://www.cdc.gov/diabetes/data/statistics-report/index.html</ext-link></comment></element-citation></ref><ref id="B2" content-type="article"><label>2</label><element-citation publication-type="journal"><collab>US Preventive Services Task Force</collab><article-title>Screening for prediabetes and Type 2 diabetes</article-title><source><italic toggle="yes">Journal of the American Medical Association</italic></source><year>2021</year><volume>326</volume><issue>8</issue><fpage>736</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1001/jama.2021.12531</pub-id><pub-id pub-id-type="pmid">34427594</pub-id></element-citation></ref><ref id="B3" content-type="article"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnett</surname><given-names>M. J.</given-names></name><name name-style="western"><surname>Thorpe</surname><given-names>R. J.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Gaskin</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Bowie</surname><given-names>J. V.</given-names></name><name name-style="western"><surname>LaVeist</surname><given-names>T. A.</given-names></name></person-group><article-title>Race, medical mistrust, and segregation in primary care as usual source of care: findings from the exploring health disparities in integrated communities study</article-title><source><italic toggle="yes">Journal of Urban Health</italic></source><year>2016</year><volume>93</volume><issue>3</issue><fpage>456</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1007/s11524-016-0054-9</pub-id><pub-id pub-id-type="other">2-s2.0-84969786237</pub-id><pub-id pub-id-type="pmid">27193595</pub-id><pub-id pub-id-type="pmcid">PMC4899337</pub-id></element-citation></ref><ref id="B4" content-type="article"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vogel</surname><given-names>J. A.</given-names></name><name name-style="western"><surname>Rising</surname><given-names>K. L.</given-names></name><name name-style="western"><surname>Jones</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>M. L.</given-names></name><name name-style="western"><surname>Ginde</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Havranek</surname><given-names>E. P.</given-names></name></person-group><article-title>Reasons patients choose the emergency department over primary care: a qualitative metasynthesis</article-title><source><italic toggle="yes">Journal of General Internal Medicine</italic></source><year>2019</year><volume>34</volume><issue>11</issue><fpage>2610</fpage><lpage>2619</lpage><pub-id pub-id-type="doi">10.1007/s11606-019-05128-x</pub-id><pub-id pub-id-type="other">2-s2.0-85071177201</pub-id><pub-id pub-id-type="pmid">31428988</pub-id><pub-id pub-id-type="pmcid">PMC6848423</pub-id></element-citation></ref><ref id="B5" content-type="article"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Selby</surname><given-names>S.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>E.</given-names></name><name name-style="western"><surname>Lang</surname><given-names>E.</given-names></name></person-group><article-title>Emergency departments as the health safety nets of society: a descriptive and multicenter analysis of social worker support in the emergency room</article-title><source><italic toggle="yes">Cureus</italic></source><year>2018</year><volume>10</volume><issue>9</issue><pub-id pub-id-type="publisher-id">e3247</pub-id><pub-id pub-id-type="doi">10.7759/cureus.3247</pub-id><pub-id pub-id-type="pmid">30416898</pub-id><pub-id pub-id-type="pmcid">PMC6217866</pub-id></element-citation></ref><ref id="B6" content-type="article"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ginde</surname><given-names>A. A.</given-names></name><name name-style="western"><surname>Cagliero</surname><given-names>E.</given-names></name><name name-style="western"><surname>Nathan</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Camargo</surname><given-names>C. A.</given-names><suffix>Jr.</suffix></name></person-group><article-title>Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening</article-title><source><italic toggle="yes">Academic Emergency Medicine</italic></source><year>2008</year><volume>15</volume><issue>12</issue><fpage>1241</fpage><lpage>1247</lpage><pub-id pub-id-type="doi">10.1111/j.1553-2712.2008.00240.x</pub-id><pub-id pub-id-type="other">2-s2.0-57349164417</pub-id><pub-id pub-id-type="pmid">18785943</pub-id></element-citation></ref><ref id="B7" content-type="article"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jelinek</surname><given-names>G. A.</given-names></name><name name-style="western"><surname>Weiland</surname><given-names>T. J.</given-names></name><name name-style="western"><surname>Moore</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Screening for type 2 diabetes with random finger-prick glucose and bedside HbA1c in an Australian emergency department</article-title><source><italic toggle="yes">Emergency Medicine Australasia</italic></source><year>2010</year><volume>22</volume><issue>5</issue><fpage>427</fpage><lpage>434</lpage><pub-id pub-id-type="doi">10.1111/j.1742-6723.2010.01333.x</pub-id><pub-id pub-id-type="other">2-s2.0-78650321201</pub-id><pub-id pub-id-type="pmid">21040483</pub-id></element-citation></ref><ref id="B8" content-type="misc"><label>8</label><element-citation publication-type="other"><collab>Centers for Medicare &amp; Medicaid Services</collab><article-title>Emergency Medical Treatment &amp; Labor Act (EMTALA)</article-title><comment>Updated 09/06/2023. Accessed November 15, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cms.gov/medicare/regulations-guidance/legislation/emergency-medical-treatment-labor-act" ext-link-type="uri">https://www.cms.gov/medicare/regulations-guidance/legislation/emergency-medical-treatment-labor-act</ext-link></comment></element-citation></ref><ref id="B9" content-type="article"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanchate</surname><given-names>A. D.</given-names></name><name name-style="western"><surname>Dyer</surname><given-names>K. S.</given-names></name><name name-style="western"><surname>Paasche-Orlow</surname><given-names>M. K.</given-names></name><etal/></person-group><article-title>Disparities in emergency department visits among collocated racial/ethnic Medicare enrollees</article-title><source><italic toggle="yes">Annals of Emergency Medicine</italic></source><year>2019</year><volume>73</volume><issue>3</issue><fpage>225</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2018.09.007</pub-id><pub-id pub-id-type="other">2-s2.0-85055548928</pub-id><pub-id pub-id-type="pmid">30798793</pub-id></element-citation></ref><ref id="B10" content-type="article"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liaw</surname><given-names>W.</given-names></name><name name-style="western"><surname>Petterson</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rabin</surname><given-names>D. L.</given-names></name><name name-style="western"><surname>Bazemore</surname><given-names>A.</given-names></name></person-group><article-title>The impact of insurance and a usual source of care on emergency department use in the United States</article-title><source><italic toggle="yes">International Journal of Family Medicine</italic></source><year>2014</year><volume>2014</volume><issue>1</issue><pub-id pub-id-type="publisher-id">842847</pub-id><pub-id pub-id-type="doi">10.1155/2014/842847</pub-id><pub-id pub-id-type="pmid">24678420</pub-id><pub-id pub-id-type="pmcid">PMC3941574</pub-id></element-citation></ref><ref id="B11" content-type="incollection"><label>11</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Zimmermann</surname><given-names>T.</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Menzies</surname><given-names>T.</given-names></name><name name-style="western"><surname>Williams</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zimmermann</surname><given-names>T.</given-names></name></person-group><article-title>One size does not fit all</article-title><source><italic toggle="yes">Perspectives on data science for software engineering</italic></source><year>2016</year><publisher-name>Morgan Kaufmann</publisher-name><fpage>347</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-804206-9.00063-5</pub-id></element-citation></ref><ref id="B12" content-type="article"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van Calster</surname><given-names>B.</given-names></name><name name-style="western"><surname>Steyerberg</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Wynants</surname><given-names>L.</given-names></name><name name-style="western"><surname>van Smeden</surname><given-names>M.</given-names></name></person-group><article-title>There is no such thing as a validated prediction model</article-title><source><italic toggle="yes">BMC Medicine</italic></source><year>2023</year><volume>21</volume><issue>1</issue><fpage>p. 70</fpage><pub-id pub-id-type="doi">10.1186/s12916-023-02779-w</pub-id><pub-id pub-id-type="pmid">36829188</pub-id><pub-id pub-id-type="pmcid">PMC9951847</pub-id></element-citation></ref><ref id="B13" content-type="article"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Smeden</surname><given-names>M.</given-names></name><name name-style="western"><surname>Reitsma</surname><given-names>J. B.</given-names></name><name name-style="western"><surname>Riley</surname><given-names>R. D.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Moons</surname><given-names>K. G. M.</given-names></name></person-group><article-title>Clinical prediction models: diagnosis versus prognosis</article-title><source><italic toggle="yes">Journal of Clinical Epidemiology</italic></source><year>2021</year><volume>132</volume><fpage>142</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2021.01.009</pub-id><pub-id pub-id-type="pmid">33775387</pub-id></element-citation></ref><ref id="B14" content-type="article"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name></person-group><article-title>Overview of clinical prediction models</article-title><source><italic toggle="yes">Annals of Translational Medicine</italic></source><year>2020</year><volume>8</volume><issue>4</issue><fpage>p. 71</fpage><pub-id pub-id-type="doi">10.21037/atm.2019.11.121</pub-id><pub-id pub-id-type="pmid">32175364</pub-id><pub-id pub-id-type="pmcid">PMC7049012</pub-id></element-citation></ref><ref id="B15" content-type="article"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heikes</surname><given-names>K. E.</given-names></name><name name-style="western"><surname>Eddy</surname><given-names>D. M.</given-names></name><name name-style="western"><surname>Arondekar</surname><given-names>B.</given-names></name><name name-style="western"><surname>Schlessinger</surname><given-names>L.</given-names></name></person-group><article-title>Diabetes risk calculator</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2008</year><volume>31</volume><issue>5</issue><fpage>1040</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.2337/dc07-1150</pub-id><pub-id pub-id-type="other">2-s2.0-48649092511</pub-id><pub-id pub-id-type="pmid">18070993</pub-id></element-citation></ref><ref id="B16" content-type="article"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Hu</surname><given-names>G.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name></person-group><article-title>Evaluation of Finnish diabetes risk score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010</article-title><source><italic toggle="yes">PLoS One</italic></source><year>2014</year><volume>9</volume><issue>5</issue><pub-id pub-id-type="publisher-id">e97865</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0097865</pub-id><pub-id pub-id-type="other">2-s2.0-84901352607</pub-id><pub-id pub-id-type="pmcid">PMC4031122</pub-id><pub-id pub-id-type="pmid">24852786</pub-id></element-citation></ref><ref id="B17" content-type="article"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Magliano</surname><given-names>D. J.</given-names></name><name name-style="western"><surname>Balkau</surname><given-names>B.</given-names></name><etal/></person-group><article-title>AUSDRISK: an Australian Type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures</article-title><source><italic toggle="yes">Medical Journal of Australia</italic></source><year>2010</year><volume>192</volume><issue>4</issue><fpage>197</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.5694/j.1326-5377.2010.tb03507.x</pub-id><pub-id pub-id-type="pmid">20170456</pub-id></element-citation></ref><ref id="B18" content-type="article"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buijsse</surname><given-names>B.</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>R. K.</given-names></name><name name-style="western"><surname>Griffin</surname><given-names>S. J.</given-names></name><name name-style="western"><surname>Schulze</surname><given-names>M. B.</given-names></name></person-group><article-title>Risk assessment tools for identifying individuals at risk of developing Type 2 diabetes</article-title><source><italic toggle="yes">Epidemiologic Reviews</italic></source><year>2011</year><volume>33</volume><issue>1</issue><fpage>46</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1093/epirev/mxq019</pub-id><pub-id pub-id-type="other">2-s2.0-79960505344</pub-id><pub-id pub-id-type="pmid">21622851</pub-id><pub-id pub-id-type="pmcid">PMC3132807</pub-id></element-citation></ref><ref id="B19" content-type="article"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herman</surname><given-names>W. H.</given-names></name></person-group><article-title>Predicting risk for diabetes: choosing (or building) the right model</article-title><source><italic toggle="yes">Annals of Internal Medicine</italic></source><year>2009</year><volume>150</volume><issue>11</issue><fpage>812</fpage><lpage>814</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-150-11-200906020-00010</pub-id><pub-id pub-id-type="other">2-s2.0-66649125311</pub-id><pub-id pub-id-type="pmid">19487716</pub-id></element-citation></ref><ref id="B20" content-type="article"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Juarez</surname><given-names>L. D.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Agne</surname><given-names>A. A.</given-names></name><etal/></person-group><article-title>Diabetes risk scores for Hispanics living in the United States: a systematic review</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2018</year><volume>142</volume><fpage>120</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2018.05.009</pub-id><pub-id pub-id-type="other">2-s2.0-85047932594</pub-id><pub-id pub-id-type="pmid">29852236</pub-id><pub-id pub-id-type="pmcid">PMC6557572</pub-id></element-citation></ref><ref id="B21" content-type="article"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Danielson</surname><given-names>K. K.</given-names></name><name name-style="western"><surname>Rydzon</surname><given-names>B.</given-names></name><name name-style="western"><surname>Nicosia</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Prevalence of undiagnosed diabetes identified by a novel electronic medical record diabetes screening program in an urban emergency department in the US</article-title><source><italic toggle="yes">JAMA Network Open</italic></source><year>2023</year><volume>6</volume><issue>1</issue><pub-id pub-id-type="publisher-id">e2253275</pub-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.53275</pub-id><pub-id pub-id-type="pmid">36701158</pub-id><pub-id pub-id-type="pmcid">PMC9880794</pub-id></element-citation></ref><ref id="B22" content-type="article"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Collins</surname><given-names>G. S.</given-names></name><name name-style="western"><surname>Reitsma</surname><given-names>J. B.</given-names></name><name name-style="western"><surname>Altman</surname><given-names>D. G.</given-names></name><name name-style="western"><surname>Moons</surname><given-names>K. G. M.</given-names></name></person-group><article-title>Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement</article-title><source><italic toggle="yes">BMC Medicine</italic></source><year>2015</year><volume>13</volume><issue>1</issue><fpage>p. 1</fpage><pub-id pub-id-type="doi">10.1186/s12916-014-0241-z</pub-id><pub-id pub-id-type="other">2-s2.0-84924036082</pub-id><pub-id pub-id-type="pmid">25563062</pub-id><pub-id pub-id-type="pmcid">PMC4284921</pub-id></element-citation></ref><ref id="B23" content-type="article"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>American</surname><given-names>D. A.</given-names></name></person-group><article-title>2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2020</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2020</year><volume>43</volume><issue>Supplement_1</issue><fpage>S14</fpage><lpage>S31</lpage><pub-id pub-id-type="doi">10.2337/dc20-S002</pub-id><pub-id pub-id-type="pmid">31862745</pub-id></element-citation></ref><ref id="B24" content-type="article"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schlesinger</surname><given-names>S.</given-names></name><name name-style="western"><surname>Neuenschwander</surname><given-names>M.</given-names></name><name name-style="western"><surname>Barbaresko</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies</article-title><source><italic toggle="yes">Diabetologia</italic></source><year>2022</year><volume>65</volume><issue>2</issue><fpage>275</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1007/s00125-021-05592-3</pub-id><pub-id pub-id-type="pmid">34718834</pub-id><pub-id pub-id-type="pmcid">PMC8741660</pub-id></element-citation></ref><ref id="B25" content-type="incollection"><label>25</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Menard</surname><given-names>S. W.</given-names></name></person-group><article-title>Applied Logistic Regression Analysis</article-title><source><italic toggle="yes">Sage University papers Quantitative applications in the social sciences</italic></source><year>2002</year><edition>2nd</edition><publisher-name>Sage Publications</publisher-name></element-citation></ref><ref id="B26" content-type="incollection"><label>26</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Steyerberg</surname><given-names>E. W.</given-names></name></person-group><article-title>Clinical prediction models: a practical approach to development, validation, and updating</article-title><source><italic toggle="yes">Statistics for biology and health</italic></source><year>2009</year><publisher-name>Springer</publisher-name></element-citation></ref><ref id="B27" content-type="article"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Austin</surname><given-names>P. C.</given-names></name></person-group><article-title>Bootstrap model selection had similar performance for selecting authentic and noise variables compared to backward variable elimination: a simulation study</article-title><source><italic toggle="yes">Journal of Clinical Epidemiology</italic></source><year>2008</year><volume>61</volume><issue>10</issue><fpage>p. 1009</fpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2007.11.014</pub-id><pub-id pub-id-type="other">2-s2.0-50249134209</pub-id><pub-id pub-id-type="pmid">18539429</pub-id></element-citation></ref><ref id="B28" content-type="article"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steyerberg</surname><given-names>E. W.</given-names></name><name name-style="western"><surname>Vickers</surname><given-names>A. J.</given-names></name><name name-style="western"><surname>Cook</surname><given-names>N. R.</given-names></name><etal/></person-group><article-title>Assessing the performance of prediction models: a framework for traditional and novel measures</article-title><source><italic toggle="yes">Epidemiology</italic></source><year>2010</year><volume>21</volume><issue>1</issue><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1097/EDE.0b013e3181c30fb2</pub-id><pub-id pub-id-type="other">2-s2.0-73849094087</pub-id><pub-id pub-id-type="pmid">20010215</pub-id><pub-id pub-id-type="pmcid">PMC3575184</pub-id></element-citation></ref><ref id="B29" content-type="article"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leisman</surname><given-names>D. E.</given-names></name><name name-style="western"><surname>Harhay</surname><given-names>M. O.</given-names></name><name name-style="western"><surname>Lederer</surname><given-names>D. J.</given-names></name><etal/></person-group><article-title>Development and reporting of prediction models: guidance for authors From editors of respiratory, sleep, and critical care journals</article-title><source><italic toggle="yes">Critical Care Medicine</italic></source><year>2020</year><volume>48</volume><issue>5</issue><fpage>623</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1097/CCM.0000000000004246</pub-id><pub-id pub-id-type="pmid">32141923</pub-id><pub-id pub-id-type="pmcid">PMC7161722</pub-id></element-citation></ref><ref id="B30" content-type="article"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coughlin</surname><given-names>S. S.</given-names></name><name name-style="western"><surname>Trock</surname><given-names>B.</given-names></name><name name-style="western"><surname>Criqui</surname><given-names>M. H.</given-names></name><name name-style="western"><surname>Pickle</surname><given-names>L. W.</given-names></name><name name-style="western"><surname>Browner</surname><given-names>D.</given-names></name><name name-style="western"><surname>Tefft</surname><given-names>M. C.</given-names></name></person-group><article-title>The logistic modeling of sensitivity, specificity, and predictive value of a diagnostic test</article-title><source><italic toggle="yes">Journal of Clinical Epidemiology</italic></source><year>1992</year><volume>45</volume><issue>1</issue><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1016/0895-4356(92)90180-u</pub-id><pub-id pub-id-type="other">2-s2.0-0026556877</pub-id><pub-id pub-id-type="pmid">1738006</pub-id></element-citation></ref><ref id="B31" content-type="article"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lindstr&#246;m</surname><given-names>J.</given-names></name><name name-style="western"><surname>Tuomilehto</surname><given-names>J.</given-names></name></person-group><article-title>The diabetes risk score</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2003</year><volume>26</volume><issue>3</issue><fpage>725</fpage><lpage>731</lpage><pub-id pub-id-type="doi">10.2337/diacare.26.3.725</pub-id><pub-id pub-id-type="other">2-s2.0-0042743790</pub-id><pub-id pub-id-type="pmid">12610029</pub-id></element-citation></ref><ref id="B32" content-type="article"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neves</surname><given-names>J. S.</given-names></name><name name-style="western"><surname>Newman</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bostrom</surname><given-names>J. A.</given-names></name><etal/></person-group><article-title>Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes</article-title><source><italic toggle="yes">Diabetes Research and Clinical Practice</italic></source><year>2022</year><volume>190</volume><pub-id pub-id-type="publisher-id">109980</pub-id><pub-id pub-id-type="doi">10.1016/j.diabres.2022.109980</pub-id><pub-id pub-id-type="pmid">35787415</pub-id></element-citation></ref><ref id="B33" content-type="misc"><label>33</label><element-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Cairns</surname><given-names>C.</given-names></name><name name-style="western"><surname>Kang</surname><given-names>K.</given-names></name></person-group><article-title>National Hospital Ambulatory Medical Care Survey: 2021 emergency department summary tables</article-title><comment>Accessed October 27, 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHAMCS/doc21-ed-508.pdf" ext-link-type="uri">https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHAMCS/doc21-ed-508.pdf</ext-link></comment></element-citation></ref><ref id="B34" content-type="article"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Urbanoski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>J.</given-names></name><name name-style="western"><surname>Rehm</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kurdyak</surname><given-names>P.</given-names></name></person-group><article-title>Frequent use of emergency departments for mental and substance use disorders</article-title><source><italic toggle="yes">Emergency Medicine Journal</italic></source><year>2018</year><volume>35</volume><issue>4</issue><fpage>220</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.1136/emermed-2015-205554</pub-id><pub-id pub-id-type="other">2-s2.0-85044844135</pub-id><pub-id pub-id-type="pmid">29311114</pub-id></element-citation></ref><ref id="B35" content-type="article"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korthuis</surname><given-names>P. T.</given-names></name><name name-style="western"><surname>Edelman</surname><given-names>E. J.</given-names></name></person-group><article-title>Substance use and the HIV care continuum: important advances</article-title><source><italic toggle="yes">Addiction Science &amp; Clinical Practice</italic></source><year>2018</year><volume>13</volume><issue>1</issue><fpage>p. 13</fpage><pub-id pub-id-type="doi">10.1186/s13722-018-0114-4</pub-id><pub-id pub-id-type="other">2-s2.0-85067172842</pub-id><pub-id pub-id-type="pmcid">PMC5848588</pub-id><pub-id pub-id-type="pmid">29530080</pub-id></element-citation></ref><ref id="B36" content-type="article"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McNeely</surname><given-names>J.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>P. C.</given-names></name><name name-style="western"><surname>Rieckmann</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Barriers and facilitators affecting the implementation of substance use screening in primary care clinics: a qualitative study of patients, providers, and staff</article-title><source><italic toggle="yes">Addiction Science &amp; Clinical Practice</italic></source><year>2018</year><volume>13</volume><issue>1</issue><fpage>p. 8</fpage><pub-id pub-id-type="doi">10.1186/s13722-018-0110-8</pub-id><pub-id pub-id-type="other">2-s2.0-85058909409</pub-id><pub-id pub-id-type="pmid">29628018</pub-id><pub-id pub-id-type="pmcid">PMC5890352</pub-id></element-citation></ref><ref id="B37" content-type="article"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuzaki</surname><given-names>M.</given-names></name><name name-style="western"><surname>Vu</surname><given-names>Q. M.</given-names></name><name name-style="western"><surname>Gwadz</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Perceived access and barriers to care among illicit drug users and hazardous drinkers: findings from the seek, test, treat, and retain data harmonization initiative (STTR)</article-title><source><italic toggle="yes">BMC Public Health</italic></source><year>2018</year><volume>18</volume><issue>1</issue><fpage>p. 366</fpage><pub-id pub-id-type="doi">10.1186/s12889-018-5291-2</pub-id><pub-id pub-id-type="other">2-s2.0-85044207835</pub-id><pub-id pub-id-type="pmid">29554894</pub-id><pub-id pub-id-type="pmcid">PMC5859651</pub-id></element-citation></ref><ref id="B38" content-type="article"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horigian</surname><given-names>V. E.</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>R. D.</given-names></name><name name-style="western"><surname>Duan</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Untreated substance use disorder affects glycemic control: results in patients with type 2 diabetes served within a network of community-based healthcare centers in Florida</article-title><source><italic toggle="yes">Frontiers in Public Health</italic></source><year>2023</year><volume>11</volume><pub-id pub-id-type="publisher-id">1122455</pub-id><pub-id pub-id-type="doi">10.3389/fpubh.2023.1122455</pub-id><pub-id pub-id-type="pmid">37006591</pub-id><pub-id pub-id-type="pmcid">PMC10060525</pub-id></element-citation></ref><ref id="B39" content-type="article"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tilbrook</surname><given-names>D.</given-names></name><name name-style="western"><surname>Jacob</surname><given-names>J.</given-names></name><name name-style="western"><surname>Parsons</surname><given-names>P.</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>C.</given-names></name><name name-style="western"><surname>Loewen</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>L.</given-names></name></person-group><article-title>Opioid use disorder and Type 2 diabetes mellitus: effect of participation in buprenorphine-naloxone substitution programs on glycemic control</article-title><source><italic toggle="yes">Canadian Family Physician</italic></source><year>2017</year><volume>63</volume><issue>7</issue><fpage>e350</fpage><lpage>e354</lpage><pub-id pub-id-type="pmid">28701461</pub-id><pub-id pub-id-type="pmcid">PMC5507246</pub-id></element-citation></ref><ref id="B40" content-type="article"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pastor</surname><given-names>A.</given-names></name><name name-style="western"><surname>Conn</surname><given-names>J.</given-names></name><name name-style="western"><surname>Mac Isaac</surname><given-names>R. J.</given-names></name><name name-style="western"><surname>Bonomo</surname><given-names>Y.</given-names></name></person-group><article-title>Alcohol and illicit drug use in people with diabetes</article-title><source><italic toggle="yes">The Lancet Diabetes and Endocrinology</italic></source><year>2020</year><volume>8</volume><issue>3</issue><fpage>239</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1016/S2213-8587(19)30410-3</pub-id><pub-id pub-id-type="pmid">31958403</pub-id></element-citation></ref><ref id="B41" content-type="article"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>L.-T.</given-names></name><name name-style="western"><surname>Ghitza</surname><given-names>U. E.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Spratt</surname><given-names>S.</given-names></name><name name-style="western"><surname>Swartz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Mannelli</surname><given-names>P.</given-names></name></person-group><article-title>Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes</article-title><source><italic toggle="yes">Drug and Alcohol Dependence</italic></source><year>2018</year><volume>186</volume><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2018.01.008</pub-id><pub-id pub-id-type="other">2-s2.0-85043976451</pub-id><pub-id pub-id-type="pmid">29554592</pub-id><pub-id pub-id-type="pmcid">PMC5959045</pub-id></element-citation></ref><ref id="B42" content-type="article"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galea</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vlahov</surname><given-names>D.</given-names></name></person-group><article-title>Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration</article-title><source><italic toggle="yes">Public Health Reports</italic></source><year>2002</year><volume>117</volume><issue>Supplement 1</issue><fpage>S135</fpage><lpage>S145</lpage><pub-id pub-id-type="pmid">12435837</pub-id><pub-id pub-id-type="pmcid">PMC1913691</pub-id></element-citation></ref><ref id="B43" content-type="article"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hill-Briggs</surname><given-names>F.</given-names></name><name name-style="western"><surname>Adler</surname><given-names>N. E.</given-names></name><name name-style="western"><surname>Berkowitz</surname><given-names>S. A.</given-names></name><etal/></person-group><article-title>Social determinants of health and diabetes: a scientific review</article-title><source><italic toggle="yes">Diabetes Care</italic></source><year>2020</year><volume>44</volume><issue>1</issue><fpage>258</fpage><lpage>279</lpage><pub-id pub-id-type="doi">10.2337/dci20-0053</pub-id><pub-id pub-id-type="pmid">33139407</pub-id><pub-id pub-id-type="pmcid">PMC7783927</pub-id></element-citation></ref><ref id="B44" content-type="article"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>M. R.</given-names></name><name name-style="western"><surname>Piette</surname><given-names>J. D.</given-names></name><name name-style="western"><surname>Resnicow</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kowalski-Dobson</surname><given-names>T.</given-names></name><name name-style="western"><surname>Heisler</surname><given-names>M.</given-names></name></person-group><article-title>Social determinants of health, cost-related nonadherence, and cost-reducing behaviors among adults with diabetes: findings from the National Health Interview Survey</article-title><source><italic toggle="yes">Medical Care</italic></source><year>2016</year><volume>54</volume><issue>8</issue><fpage>796</fpage><lpage>803</lpage><pub-id pub-id-type="doi">10.1097/mlr.0000000000000565</pub-id><pub-id pub-id-type="other">2-s2.0-84970046071</pub-id><pub-id pub-id-type="pmid">27219636</pub-id><pub-id pub-id-type="pmcid">PMC4945373</pub-id></element-citation></ref><ref id="B45" content-type="incollection"><label>45</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Polubriaginof</surname><given-names>F.</given-names></name><name name-style="western"><surname>Tatonetti</surname><given-names>N. P.</given-names></name><name name-style="western"><surname>Vawdrey</surname><given-names>D. K.</given-names></name></person-group><article-title>An assessment of family history information captured in an electronic health record</article-title><source><italic toggle="yes">AMIA Annual Symposium Proceedings. Vol. 2015</italic></source><year>2015</year><publisher-name>American Medical Informatics Association</publisher-name><fpage>2035</fpage><lpage>2042</lpage><pub-id pub-id-type="pmcid">PMC4765557</pub-id><pub-id pub-id-type="pmid">26958303</pub-id></element-citation></ref><ref id="B46" content-type="article"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riley</surname><given-names>R. D.</given-names></name><name name-style="western"><surname>Collins</surname><given-names>G. S.</given-names></name></person-group><article-title>Stability of clinical prediction models developed using statistical or machine learning methods</article-title><source><italic toggle="yes">Biometrical Journal</italic></source><year>2023</year><volume>65</volume><issue>8</issue><pub-id pub-id-type="doi">10.1002/bimj.202200302</pub-id><pub-id pub-id-type="publisher-id">e2200302</pub-id><pub-id pub-id-type="pmid">37466257</pub-id><pub-id pub-id-type="pmcid">PMC10952221</pub-id></element-citation></ref><ref id="B47" content-type="article"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shmueli</surname><given-names>G.</given-names></name></person-group><article-title>To Explain or to Predict?</article-title><source><italic toggle="yes">Statistical Science</italic></source><year>2010</year><volume>25</volume><issue>3</issue><fpage>289</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1214/10-STS330</pub-id><pub-id pub-id-type="other">2-s2.0-78751611452</pub-id></element-citation></ref><ref id="B48" content-type="article"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arif</surname><given-names>S.</given-names></name><name name-style="western"><surname>MacNeil</surname><given-names>M. A.</given-names></name></person-group><article-title>Predictive models aren't for causal inference</article-title><source><italic toggle="yes">Ecology Letters</italic></source><year>2022</year><volume>25</volume><issue>8</issue><fpage>1741</fpage><lpage>1745</lpage><pub-id pub-id-type="doi">10.1111/ele.14033</pub-id><pub-id pub-id-type="pmid">35672133</pub-id></element-citation></ref><ref id="B49" content-type="article"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cassell</surname><given-names>K.</given-names></name><name name-style="western"><surname>Zipfel</surname><given-names>C. M.</given-names></name><name name-style="western"><surname>Bansal</surname><given-names>S.</given-names></name><name name-style="western"><surname>Weinberger</surname><given-names>D. M.</given-names></name></person-group><article-title>Trends in non-COVID-19 hospitalizations prior to and during the COVID-19 pandemic period, United States, 2017&#8211;2021</article-title><source><italic toggle="yes">Nature Communications</italic></source><year>2022</year><volume>13</volume><issue>1</issue><fpage>p. 5930</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-33686-y</pub-id><pub-id pub-id-type="pmid">36209210</pub-id><pub-id pub-id-type="pmcid">PMC9546751</pub-id></element-citation></ref><ref id="B50" content-type="article"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>A. R.</given-names></name><name name-style="western"><surname>DeVies</surname><given-names>J.</given-names></name><name name-style="western"><surname>Carey</surname><given-names>K.</given-names></name><etal/></person-group><article-title>COVID-19 pandemic-associated changes in overall emergency department visits by age group, race, and ethnicity - United States, January 2019-April 2022</article-title><source><italic toggle="yes">The American Journal of Emergency Medicine</italic></source><year>2023</year><volume>69</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1016/j.ajem.2023.04.005</pub-id><pub-id pub-id-type="pmid">37087809</pub-id><pub-id pub-id-type="pmcid">PMC10104597</pub-id></element-citation></ref><ref id="B51" content-type="article"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O'Jiaku-Okorie</surname><given-names>A.</given-names></name><name name-style="western"><surname>Yin</surname><given-names>X.</given-names></name><name name-style="western"><surname>Lucas</surname><given-names>C.</given-names></name></person-group><article-title>QuickStats: Rate of emergency department visits for substance use disorders among adults aged&#8805; 18 years, by age group--National Hospital Ambulatory Medical Care Survey, United States, 2018-2019 and 2020-2021</article-title><source><italic toggle="yes">MMWR: Morbidity and Mortality Weekly Report</italic></source><year>2023</year><volume>72</volume><issue>39</issue><fpage>p. e1073</fpage><pub-id pub-id-type="doi">10.15585/mmwr.mm7239a6</pub-id><pub-id pub-id-type="pmid">37768878</pub-id><pub-id pub-id-type="pmcid">PMC10545432</pub-id></element-citation></ref><ref id="B52" content-type="misc"><label>52</label><element-citation publication-type="other"><collab>Substance Abuse and Mental Health Services Administration</collab><comment>Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2022 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://store.samhsa.gov/sites/default/files/pep23-07-03-001.pdf" ext-link-type="uri">https://store.samhsa.gov/sites/default/files/pep23-07-03-001.pdf</ext-link></comment><pub-id pub-id-type="pmid">27631059</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="tab1" orientation="portrait"><label>Table 1</label><caption><p>Sample characteristics of cohort as described by candidate predictor variables and associations with elevated HbA1c (<italic toggle="yes">n</italic> = 570).</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" colspan="1"/><th align="center" colspan="5" rowspan="1">
<bold>HbA1c test</bold>
</th></tr><tr><th align="center" colspan="2" rowspan="1">
<bold>Normal (&lt;&#8201;5.7%)</bold>
<break/>
<bold>n</bold> = 331</th><th align="center" colspan="2" rowspan="1">
<bold>Elevated (&#8805;&#8201;5.7%)</bold>
<break/>
<bold>n</bold> = 259</th><th align="center" rowspan="1" colspan="1">
<bold>p</bold>
<bold> value</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, mean (SD)</td><td align="center" rowspan="1" colspan="1">47.9</td><td align="center" rowspan="1" colspan="1">(17.7)</td><td align="center" rowspan="1" colspan="1">56.6</td><td align="center" rowspan="1" colspan="1">(14.9)</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Female</td><td align="center" rowspan="1" colspan="1">162</td><td align="center" rowspan="1" colspan="1">(52.1)</td><td align="center" rowspan="1" colspan="1">124</td><td align="center" rowspan="1" colspan="1">(47.9)</td><td align="center" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Male</td><td align="center" rowspan="1" colspan="1">149</td><td align="center" rowspan="1" colspan="1">(47.9)</td><td align="center" rowspan="1" colspan="1">135</td><td align="center" rowspan="1" colspan="1">(52.1)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Race/ethnicity, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Hispanic, White</td><td align="center" rowspan="1" colspan="1">59</td><td align="center" rowspan="1" colspan="1">(19.0)</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">(13.1)</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Hispanic, Black or African American</td><td align="center" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1">(40.2)</td><td align="center" rowspan="1" colspan="1">128</td><td align="center" rowspan="1" colspan="1">(49.4)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Non-Hispanic, Asian</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">(6.9)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hispanic, Latino/a, or Spanish origin</td><td align="center" rowspan="1" colspan="1">97</td><td align="center" rowspan="1" colspan="1">(31.2)</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">(26.6)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other/unknown</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">(5.8)</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Insurance, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Commercial/private</td><td align="center" rowspan="1" colspan="1">91</td><td align="center" rowspan="1" colspan="1">(29.3)</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">(25.9)</td><td align="center" rowspan="1" colspan="1">0.34</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Medicaid</td><td align="center" rowspan="1" colspan="1">120</td><td align="center" rowspan="1" colspan="1">(38.6)</td><td align="center" rowspan="1" colspan="1">93</td><td align="center" rowspan="1" colspan="1">(35.9)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Medicare</td><td align="center" rowspan="1" colspan="1">76</td><td align="center" rowspan="1" colspan="1">(24.4)</td><td align="center" rowspan="1" colspan="1">69</td><td align="center" rowspan="1" colspan="1">(26.6)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Other/unknown/uninsured</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">(7.7)</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">(11.6)</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Past medical history, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hypertension</td><td align="center" rowspan="1" colspan="1">98</td><td align="center" rowspan="1" colspan="1">(31.5)</td><td align="center" rowspan="1" colspan="1">124</td><td align="center" rowspan="1" colspan="1">(47.9)</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Obesity</td><td align="center" rowspan="1" colspan="1">117</td><td align="center" rowspan="1" colspan="1">(37.6)</td><td align="center" rowspan="1" colspan="1">121</td><td align="center" rowspan="1" colspan="1">(46.7)</td><td align="center" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">(5.8)</td><td align="center" rowspan="1" colspan="1">46</td><td align="center" rowspan="1" colspan="1">(17.8)</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cardiovascular disorder</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">(10.9)</td><td align="center" rowspan="1" colspan="1">47</td><td align="center" rowspan="1" colspan="1">(18.1)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Arthritis</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">(4.5)</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">(10.0)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;COPD</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">(2.6)</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">(10.8)</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cancer</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">(6.1)</td><td align="center" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">(12.7)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Substance misuse</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">(5.8)</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">(13.5)</td><td align="center" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Heart failure</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">(6.2)</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Atrial fibrillation</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">(3.9)</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">(6.2)</td><td align="center" rowspan="1" colspan="1">0.20</td></tr><tr><td align="left" rowspan="1" colspan="1">Chief complaint included, <italic toggle="yes">n</italic> (%)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Back pain</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">(1.3)</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">(5.0)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Fever/chills</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">(1.6)</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">(6.6)</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Nausea/vomiting</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">(6.1)</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">(10.0)</td><td align="center" rowspan="1" colspan="1">0.08</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: COPD, chronic obstructive pulmonary disease; HbA1c, glycated hemoglobin.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="tab2" orientation="portrait"><label>Table 2</label><caption><p>Parameter estimates for final model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Parameter</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Estimate</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Standard error</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Pr</bold> &gt; |<bold>t</bold>|</th><th align="center" colspan="2" rowspan="1">
<bold>95% confidence limits</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Intercept</td><td align="center" rowspan="1" colspan="1">&#8722;3.724</td><td align="center" rowspan="1" colspan="1">0.566</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" rowspan="1" colspan="1">&#8722;4.833</td><td align="center" rowspan="1" colspan="1">&#8722;2.615</td></tr><tr><td align="left" rowspan="1" colspan="1">Age</td><td align="center" rowspan="1" colspan="1">0.045</td><td align="center" rowspan="1" colspan="1">0.009</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" rowspan="1" colspan="1">0.028</td><td align="center" rowspan="1" colspan="1">0.062</td></tr><tr><td align="left" rowspan="1" colspan="1">Race/ethnicity: Hispanic, Latino/a, or Spanish origin</td><td align="center" rowspan="1" colspan="1">0.172</td><td align="center" rowspan="1" colspan="1">0.350</td><td align="center" rowspan="1" colspan="1">0.623</td><td align="center" rowspan="1" colspan="1">&#8722;0.514</td><td align="center" rowspan="1" colspan="1">0.858</td></tr><tr><td align="left" rowspan="1" colspan="1">Race/ethnicity: non-Hispanic, Asian</td><td align="center" rowspan="1" colspan="1">1.313</td><td align="center" rowspan="1" colspan="1">0.509</td><td align="center" rowspan="1" colspan="1">0.010</td><td align="center" rowspan="1" colspan="1">0.316</td><td align="center" rowspan="1" colspan="1">2.311</td></tr><tr><td align="left" rowspan="1" colspan="1">Race/ethnicity: non-Hispanic, Black or African American</td><td align="center" rowspan="1" colspan="1">0.607</td><td align="center" rowspan="1" colspan="1">0.318</td><td align="center" rowspan="1" colspan="1">0.056</td><td align="center" rowspan="1" colspan="1">&#8722;0.016</td><td align="center" rowspan="1" colspan="1">1.229</td></tr><tr><td align="left" rowspan="1" colspan="1">Race/ethnicity: other/unknown</td><td align="center" rowspan="1" colspan="1">0.114</td><td align="center" rowspan="1" colspan="1">0.528</td><td align="center" rowspan="1" colspan="1">0.829</td><td align="center" rowspan="1" colspan="1">&#8722;0.920</td><td align="center" rowspan="1" colspan="1">1.148</td></tr><tr><td align="left" rowspan="1" colspan="1">Insurance: Medicaid</td><td align="center" rowspan="1" colspan="1">0.187</td><td align="center" rowspan="1" colspan="1">0.280</td><td align="center" rowspan="1" colspan="1">0.504</td><td align="center" rowspan="1" colspan="1">&#8722;0.362</td><td align="center" rowspan="1" colspan="1">0.736</td></tr><tr><td align="left" rowspan="1" colspan="1">Insurance: Medicare</td><td align="center" rowspan="1" colspan="1">&#8722;0.754</td><td align="center" rowspan="1" colspan="1">0.348</td><td align="center" rowspan="1" colspan="1">0.030</td><td align="center" rowspan="1" colspan="1">&#8722;1.435</td><td align="center" rowspan="1" colspan="1">&#8722;0.073</td></tr><tr><td align="left" rowspan="1" colspan="1">Insurance: other/unknown/uninsured</td><td align="center" rowspan="1" colspan="1">0.916</td><td align="center" rowspan="1" colspan="1">0.429</td><td align="center" rowspan="1" colspan="1">0.033</td><td align="center" rowspan="1" colspan="1">0.075</td><td align="center" rowspan="1" colspan="1">1.757</td></tr><tr><td align="left" rowspan="1" colspan="1">Obesity</td><td align="center" rowspan="1" colspan="1">0.939</td><td align="center" rowspan="1" colspan="1">0.240</td><td align="center" rowspan="1" colspan="1">&lt;&#8201;0.001</td><td align="center" rowspan="1" colspan="1">0.467</td><td align="center" rowspan="1" colspan="1">1.410</td></tr><tr><td align="left" rowspan="1" colspan="1">Hyperlipidemia</td><td align="center" rowspan="1" colspan="1">1.195</td><td align="center" rowspan="1" colspan="1">0.386</td><td align="center" rowspan="1" colspan="1">0.002</td><td align="center" rowspan="1" colspan="1">0.438</td><td align="center" rowspan="1" colspan="1">1.952</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td><td align="center" rowspan="1" colspan="1">1.138</td><td align="center" rowspan="1" colspan="1">0.522</td><td align="center" rowspan="1" colspan="1">0.029</td><td align="center" rowspan="1" colspan="1">0.116</td><td align="center" rowspan="1" colspan="1">2.161</td></tr><tr><td align="left" rowspan="1" colspan="1">Substance misuse</td><td align="center" rowspan="1" colspan="1">1.422</td><td align="center" rowspan="1" colspan="1">0.426</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="center" rowspan="1" colspan="1">0.588</td><td align="center" rowspan="1" colspan="1">2.256</td></tr><tr><td align="left" rowspan="1" colspan="1">Chief complaint: back pain</td><td align="center" rowspan="1" colspan="1">1.674</td><td align="center" rowspan="1" colspan="1">0.666</td><td align="center" rowspan="1" colspan="1">0.012</td><td align="center" rowspan="1" colspan="1">0.370</td><td align="center" rowspan="1" colspan="1">2.978</td></tr><tr><td align="left" rowspan="1" colspan="1">Chief complaint: fever/chills</td><td align="center" rowspan="1" colspan="1">1.507</td><td align="center" rowspan="1" colspan="1">0.635</td><td align="center" rowspan="1" colspan="1">0.018</td><td align="center" rowspan="1" colspan="1">0.262</td><td align="center" rowspan="1" colspan="1">2.752</td></tr></tbody></table></table-wrap><table-wrap position="float" id="tab3" orientation="portrait"><label>Table 3</label><caption><p>Performance fit statistic for final model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" colspan="2" rowspan="1">
<bold>Performance fit statistic</bold>
</th></tr><tr><th align="left" rowspan="1" colspan="1">
<bold>Type</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Final model</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">C-statistic</td><td align="center" rowspan="1" colspan="1">0.747</td></tr><tr><td align="left" rowspan="1" colspan="1">Hosmer&#8211;Lemeshow test</td><td align="center" rowspan="1" colspan="1">0.291</td></tr><tr><td align="left" rowspan="1" colspan="1">Brier score</td><td align="center" rowspan="1" colspan="1">0.205</td></tr><tr><td align="left" rowspan="1" colspan="1">True negative fraction (specificity)</td><td align="center" rowspan="1" colspan="1">0.710</td></tr><tr><td align="left" rowspan="1" colspan="1">True positive fraction (sensitivity)</td><td align="center" rowspan="1" colspan="1">0.700</td></tr><tr><td align="left" rowspan="1" colspan="1">Positive predictive value</td><td align="center" rowspan="1" colspan="1">0.673</td></tr><tr><td align="left" rowspan="1" colspan="1">Negative predictive value</td><td align="center" rowspan="1" colspan="1">0.735</td></tr></tbody></table></table-wrap></floats-group></article></pmc-articleset>